APOLLO HOSPITALS ENTER. L vs SENORES PHARMACEUTICALS L

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and SENORES PHARMACEUTICALS L (SENORES) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

APOLLO HOSPITALS ENTER. L and SENORES PHARMACEUTICALS L are evenly matched on the numbers (77). The breakdown below shows where each one wins.

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

65.36
P/E ratio
56.09
13.42
P/B ratio
6.58
0.11%
Dividend yield
0.00%
₹135.04
EPS
₹25.05

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
13.40%
18.00%
Return on capital
15.00%
15.00%
EBITDA margin
27.00%
7.94%
Net margin
19.27%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
162.49%
33.39%
Profit CAGR (3Y)
147.98%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.27L Cr
Market cap
₹7,026 Cr
₹25,228 Cr
Revenue
₹633 Cr
₹2,003 Cr
Net profit
₹122 Cr
0.90
Debt / equity
0.37
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 77.8% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
SENORES PHARMACEUTICALS L
  • + ["Company is expected to give good quarter"]
  • ["Stock is trading at 6.99 times its book value", "Though the company is reporting repeated profits, it is not paying out dividend", "Company has a low return on equity of 13.9% over last 3 years.", "Company might be capitalizing the interest cost", "Company has high debtors of 187 days.", "Working capital days have increased from 67.9 days to 132 days"]
APOLLO HOSPITALS ENTER. L full analysis SENORES PHARMACEUTICALS L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.